Ingrid Winkler

Associate Professor Ingrid Winkler is a Senior Research Fellow and head of the Stem Cells and Cancer group at Mater Research Institute - the University of Queensland, Brisbane, Australia. A/Prof Winkler's research focus is understanding how micro-environments in the body protect and control normal and/or malignant stem Cells. Her innovative stem cell niche research has been recognised as among ten of the best research projects in Australia (by National Health and Medical Research Council) with patents and clinical translation. A/Prof Winker's current research explores how stem cell niches change with ageing, inflammation, cancer therapy or radiation damage, with view to identify key detrimental niche components involved. This knowledge may be used to develop novel treatment strategies to improve cancer therapy outcomes, alleviate adverse cancer therapy side-effects that currently affect up tp 80% of Australian cancer therapy patientts plus facilitate healthier old age. Stem cell niches, hematopoietic stem cells, cancer therapy, ageing, inflammation, radiation damage, acute myeloid leukemia, E-selectin, bone marrow microenvironment

[2026] Endothelial protein C receptor CD201 is a better marker than SCA1 to identify mouse long-term reconstituting hematopoietic stem cells following septic challenge. Bisht, Kavita, Barbier, Valérie, Shatunova, Svetlana, Winkler, Ingrid G. and Lévesque, Jean-Pierre (2026). Experimental Hematology, 154 105326, 1-14. doi: 10.1016/j.exphem.2025.105326 [2025] G-CSF-induced pain-like behaviors can be prevented by therapeutic blockade of vascular endothelial E-selectin in mice. Winkler, Ingrid, Barbier, Valerie, Bisht, Kavita, Levesque, Jean-Pierre, Shatunova, Svetlana, Starobova, Hana and Vetter, Irina (2025). 54th Annual Scientific Meeting of the ISEH - International Society for Experimental Hematology, Kumamoto, Japan, 24-27 September 2025. Amsterdam, Netherlands: Elsevier. doi: 10.1016/j.e